Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Neuroepidemiology|January 20, 2016
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple SclerosisPrudence Tettey, Dylan Siejka, Steve Simpson, et al.
Photochemistry and Photobiology|January 15, 2013
Sun exposure over a lifetime in Australian adults from latitudinally diverse regionsRobyn M Lucas, Patricia Valery, Ingrid van der Mei, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 16, 2014
An adverse lipid profile is associated with disability and progression in disability, in people with MSPrudence Tettey, Steve Simpson, Bruce Taylor, et al.
JAMA|January 27, 2005
Exposure to infant siblings during early life and risk of multiple sclerosisAnne-Louise Ponsonby, Ingrid van der Mei, Terence Dwyer, et al.
Pharmacoepidemiology and Drug Safety|April 9, 2008
Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing dosesHelen Tremlett, Ingrid Van der Mei, Fotini Pittas, et al.
Journal of the Neurological Sciences|March 25, 2014
Adverse lipid profile is not associated with relapse risk in MS: results from an observational cohort studyPrudence Tettey, Steve Simpson, Bruce Taylor, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 15, 2022
Vitamin D metabolites and risk of first clinical diagnosis of central nervous system demyelinationCourtney Tiller, Lucinda J Black, Anne-Louise Ponsonby, et al.
BMC Pediatrics|June 10, 2022
Validity of a three-item dating abuse victimization screening tool in a 11-21 year old sampleEmily F Rothman, Julia K Campbell, Ariel M Hoch, et al.
Multiple Sclerosis and Related Disorders|February 8, 2022
Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progressionChunrong Tao, Steve Simpson-Yap, Bruce Taylor, et al.
Pageof 16